Patent · US Active

Compositions and methods for the treatment of disease associated with TRP-P8 expression

US8389730B2 · kind B2 · utility

2Cited by
11References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2011
Grant dateMar 5, 2013
Priority date
Expiry dateMay 25, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and characterizing novel small-molecule Trp-p8 modulators and methods for decreasing viability and/or inhibiting growth of Trp-p8 expressing cells, methods for activating Trp-p8-mediated cation influx, methods for stimulating apoptosis and/or necrosis, and related methods for the treatment of diseases, including cancers such as lung, breast, colon, and/or prostate cancers as well as other diseases, such as benign prostatic hyperplasia, that are associated with Trp-p8 expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.